Skip to content
Drug recall · FDA · Published July 29, 2019

Aurobindo Pharma USA Inc. recalls Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810

Aurobindo Pharma USA recalls 1000-count Simvastatin 40mg tablets due to incorrect lot and expiration dates on some bottles. Affected lots include 05318054B (exp 3/2021).

🇺🇸 FDA recall #D-1842-2019DrugAurobindo Pharma ›
Take action

Contact the company & request your remedy

Recalling firmAurobindo Pharma USA Inc.279 Princeton Hightstown Rd, N/A · East Windsor, NJ 08520-1401
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Aurobindo Pharma is recalling 1000-count Simvastatin 40mg tablets that may have incorrect lot or expiration dates. This could lead to confusion about the product's age and safety. Read more at govinfonow.com/recall/38199-aurobindo-pharma-recalls-simvastatin-40mg-tablets-incorrect-lot-exp-dates.

Source Summary by GovInfoNow · govinfonow.com/recall/38199-aurobindo-pharma-recalls-simvastatin-40mg-tablets-incorrect-lot-exp-dates · Updated October 5, 2026 · FDA enforcement record: FDA #D-1842-2019

Cite this page

“Aurobindo Pharma recalls Simvastatin 40mg tablets: Incorrect lot/exp dates.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38199-aurobindo-pharma-recalls-simvastatin-40mg-tablets-incorrect-lot-exp-dates. Based on FDA recall #D-1842-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1842-2019%22&limit=1).

Why it’s dangerous

The tablets may have incorrect lot numbers or expiration dates, which could cause confusion about when the product expires. This might lead to using expired medication or incorrect dosage information.

Who’s affected

People who own or use the recalled Simvastatin tablets. Those with the specific lot number 05318054B (expiring 3/2021) are most at risk.

How to tell if you have this one

Check the lot number on the bottle. Affected lots include 05318054B (expiring 3/2021). The product was sold with NDC 65862-053-99.

  • Brand
    Aurobindo Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Number

    Look for the lot number on the bottle. If it is 05318054B, this product is affected.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The recall is due to incorrect or missing lot and expiration dates on some bottles, specifically lot number 05318054B (expiring 3/2021).

What should I do if I have the affected lot?

Check the lot number on the bottle. If it is 05318054B, contact Aurobindo Pharma for instructions.

Is there a deadline to act?

The recall record does not specify a deadline for action.

Take action

Contact Aurobindo Pharma

We’ve drafted a message you can send Aurobindo Pharma to request your refund or repair — edit it as you like.

Subject: Recall D-1842-2019 — Aurobindo Pharma Aurobindo Pharma

Hello,

I own a Aurobindo Pharma that is covered by recall D-1842-2019 from Aurobindo Pharma.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1842-2019 (July 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1842-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA